TABLE 3.
Donor and operative characteristics by recipient midodrine use
| Donor and operative characteristics by midodrine groups | ||||
|---|---|---|---|---|
| None(N = 43) | Midodrine(N = 17) | Total(N = 60) | P | |
| Donor age | 0.989a | |||
| N | 27 | 17 | 44 | |
| Mean (SD) | 33.6 (13.6) | 33.6 (11.6) | 33.6 (12.7) | |
| Median | 35.0 | 28.0 | 33.5 | |
| Q1, Q3 | 22.0, 44.0 | 24.0, 45.0 | 23.0, 44.5 | |
| Donor sex | 0.521b | |||
| Female | 7 (25.9%) | 6 (35.3%) | 13 (29.5%) | |
| Male | 20 (74.1%) | 11 (64.7%) | 31 (70.5%) | |
| Missing | 16 | 0 | 16 | |
| Donor type | 1.000b | |||
| DBD | 42 (97.7%) | 17 (100.0%) | 59 (98.3%) | |
| DCD | 1 (2.3%) | 0 (0.0%) | 1 (1.7%) | |
| COD | 0.954b | |||
| Anoxia | 11 (40.7%) | 8 (47.1%) | 19 (43.2%) | |
| Cerebrovascular/stroke | 8 (29.6%) | 4 (23.5%) | 12 (27.3%) | |
| Head trauma | 7 (25.9%) | 5 (29.4%) | 12 (27.3%) | |
| Other | 1 (3.7%) | 0 (0.0%) | 1 (2.3%) | |
| Missing | 16 | 0 | 16 | |
| CIT (min) | 0.097c | |||
| N | 29 | 16 | 45 | |
| Mean (SD) | 485 (240) | 406 (264) | 457 (249) | |
| Median | 480 | 329 | 379 | |
| Q1, Q3 | 307, 623 | 265, 463 | 287, 588 | |
| WIT (min) | 0.694a | |||
| N | 29 | 17 | 46 | |
| Mean (SD) | 33.4 (7.6) | 34.4 (9.3) | 33.8 (8.2) | |
| Median | 33.0 | 35.0 | 34.0 | |
| Q1, Q3 | 27.0, 40.0 | 27.0, 41.0 | 27.0, 40.0 | |
| KDPI | 0.764a | |||
| N | 26 | 17 | 43 | |
| Mean (SD) | 36.5 (22.6) | 38.5 (18.5) | 37.3 (20.9) | |
| Median | 36.5 | 41.0 | 38.0 | |
| Q1, Q3 | 21.0, 47.0 | 23.0, 49.0 | 21.0, 47.0 | |
aEqual variance t test.
bFisher Exact test.
cWilcoxon test.
CIT, cold ischemia time; COD, cause of death; DBD, donation after brain death; DCD, donation after circulatory death; KDPI, kidney donor profile index; WIT, warm ischemia time.